COVID-19 has not only changed our daily routines, it also changed the traditional education system into distance learning or hybrid model. And convening classes with live and pre-recorded lessons challenged the pharmacy academics to innovate methods to engage their students in active online learning. This webinar will focus on pharmacy schools and accreditation bodies’ roles to make online learning creative and effective for students. Immersing pharmacy students in research, and meeting pharmacy students’ needs in an online environment will be addressed by the experts in their fields. Also, pharmacy students will discover enrichened ways to adjust and foster their education in online/virtual delivery.
Learning objectives:
1. To explore the roles of accreditation bodies in the quality of pharmacy programmes and transition to online
2. To determine the roles of schools of pharmacy in maintaining quality of programmes including skills development and experiential learning (especially when transitioning to online/virtual learning)
3. To describe the skills that professors/teachers must adopt/adapt to maintain quality of programmes (especially online/virtual versions)
4. To discuss how learners should adapt their learning to maintain their quality of learning during online/virtual delivery

Moderator:
- Carlo Marra, Dean School of Pharmacy University of Otago - New Zealand
Facilitator:
- Naoko Arakawa, Assistant Professor in International Pharmacy University of Nottingham- UK
Panellists:
- Vibhu Solanki, Associate Professor of Community Pharmacy and Digital Education University of Nottingham - UK
- Janet P. Engle, Executive Director Accreditation Council for Pharmacy Education- USA
- Ilkay Erdogan Orhan, Dean Gazi University, Faculty of Pharmacy - Turkey
- Yahya Choonara, Professor University of Witwatersrand - South Africa

The 3rd episode of the programme explores FIP Development Goal 16: Communicable diseases. Through this goal, we aim to oversee the prevention, surveillance, scientifically strategic management and therapeutic optimisation of communicable and vector-borne diseases. This event will take place during World Immunisation Week and it will reiterate the commitment of pharmacists, pharmaceutical scientists and pharmaceutical educators to improving vaccination coverage around the world, and to further support the prevention and management of communicable diseases.

Event outcomes:
1. Describe and explain the components of FIP DG 16 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 16 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 16
4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

Moderator:
Gonçalo Sousa Pinto, FIP Lead for Practice Development and Transformation - Spain

Facilitator:
Rúben Viegas, FIP Practice Development Projects Coordinator - Spain

Panellists:
- Ian Bates, Chair of pharmacy education, UCL, FIP Director of the Workforce Development Hub - UK
- Lars-Åke Söderlund, President, Community Pharmacy Section, FIP - Sweden
- Eduardo Savio, President Pharmaceutical Forum of the Americas - Uruguay
- Cameron Phillips, Academic and Senior Pharmacist, Flinders University College of Medicine and Public health & Flinders - Australia

Los farmacéuticos tienen una posición privilegiada para ayudar a las comunidades y a los pacientes a protegerse de las enfermedades transmitidas por vectores (ETV). En este webinar se describirán las ETV con mayor prevalencia en las Américas; posteriormente se identificaran las intervenciones farmacéuticas más relevantes en este ámbito y por último se presentarán tres experiencias desarrolladas por el Foro Farmacéutico de las Américas referentes al abordaje farmacéutico de las ETV.

Objetivos de aprendizaje:
1) Reconocer los principales conceptos relacionados con las enfermedades transmisibles por vectores.
2) Describir las características y la morbi-mortalidad de las principales enfermedades transmisibles por vectores en la región de las Américas.
3) Determinar las actividades que el farmacéutico puede desarrollar desde la farmacia para la prevención, detección, control y gestión de la farmacoterapia de las enfermedades transmisibles por vectores.
4) Identificar las experiencias desarrolladas por el Foro Farmacéutico de las Américas para apoyar las acciones de los farmacéuticos en la lucha contra las enfermedades transmisibles por arbovirus.

Moderator:
Gonçalo Sousa Pinto, Director de Desarrollo y Transformación de la Práctica Farmacéutica
Federación Internacional Farmacéutica (FIP) - Portugal
Facilitator:
Yajaira Quesada Rojas, Secretaria Técnica - Foro Farmacéutico de las Américas - Costa Rica.

Ponentes:
-Cristina Fernández Barrantes, Farmacéutica, Centro de Información de Medicamentos del Servicio de Farmacia del Hospital San Juan de Dios, San José-Costa Rica
-Nuria Montero Chinchilla, Farmacéutica, Directora de Práctica Farmacéutica
Foro Farma-Costa Rica.
-Sofía Segura Cano, Farmacéutica, Programa Institucional para la Persona Adulta y Adulta Mayor de la Universitad Costa Rica

This session targets stakeholders involved in professional and continuing pharmacy education. Its purpose is to equip educators with strategies and techniques used in cultural sensitivity training for pharmacy students, an essential component of modern pharmacy education and optimal patient care. Specifically, experts will share strategies and lessons learned from creating and tailoring educational activities within the pharmacy curriculum that address cultural sensitivity.

Learning Objectives
At the end of this session, participants will be able to:
• Identify key steps in creating activities aimed to improve cultural sensitivity among pharmacy students
• Describe strategies educators can use to engage students in learning about and addressing the needs of patients from different culture
• Consider strategies for integrating cultural sensitivity training in pharmacy curricula

Moderator:
- Dalia Bajis, FIP Lead for Provision and Partnerships, Bahrain

Panellists:
- Mohamed Amin, Associate Professor, Beirut Arab University - Lebanon
- Cherie Lucas, Senior Lecturer and Clinical Education Manager (Experiential Placements), University of Technology - Australia
- Gizem Gülpınar, Research Assistant, Ankara University - Turkey

As the second installment of the two-part series on pharmacists’ role in ensuring patient safety, this webinar will explore medicines reconciliation as an essential service in ensuring patient safety. As transitions of care bear an increased risk of medication discrepancies, which lead to adverse effects, pharmacist-led medicines reconciliation has been demonstrated to effectively resolve such discrepancies and contribute to avoiding patient harm. Pharmacy experts and FIP team members from around the world will be presenting data supporting this service in addition to the FIP toolkit on medicines reconciliation launched this February.
Learning objectives:
• Define medicines reconciliation and review data supporting the clinical and economic benefits associated with the service
• Explore examples of medicines reconciliation practices from different regions
• Become familiar with the FIP medicines reconciliation toolkit to support the advocacy and implementation of the service

Moderator:
Nam-Anh Nguyen, Medication Safety Advanced Practice Pharmacist Sir Charles Gairdner Hospital (Perth, Australia) & The Society of Hospital Pharmacists of Australia - Australia

Panellists:
- Jonathan Penm, Senior Lecturer The University of Sydney School of Pharmacy
Assistant Secretary, Hospital Pharmacy Section - Australia
- Régis Vaillancourt, Director of Pharmacy
Children’s Hospital of Eastern Ontario - Canada
- Veerle Foulon, Professor KU Leuven - Belgium
- Matthew Hung, Clinical Staff Pharmacist St. Mary’s Hospital, Montreal West Island Integrated University Health and Social Services Centre - Canada

Pharmacy technicians have a critical role in the delivery of healthcare and patient care services. This webinar will offer an overview of current research and publications about pharmacy technicians’ contributions. Speakers will also discuss the importance of data, evidence, and research related to pharmacy technician practice and describe current literature that demonstrates the value of the pharmacy support workforce.

Learning objectives:
· Understand the importance of data, evidence, and research related to the role and practice of pharmacy technicians
· Learn about the many contributions of pharmacy technicians on an international level
· Describe recent and upcoming publications regarding pharmacy technicians

Moderator:
- Ryan Burke, Director of Professional Affairs Pharmacy Technician Certification Board PTAC - United States
Co-moderator:
Teri-Lynne, Fogarty Lecturer/ Coordinator of Pharmacy technician programme Nelson Mandela University PTAC member - South Africa

Panellists:
- Kimberly McKeirnan, Associate Professor, Pharmacotherapy Director for the Center for Pharmacy Practice Research Washington State University, PTAC Member - United States
- Charlotte Verner Rossing, Director of R&D
Pharmakon, Danish College of Pharmacy Practice, Vice-chair FIP Special Interest Group on Pharmacy Practice Research - Denmark
- Tamara Köhler, Consultant and lecturer, PhD Candidate FPZ-instituut -Netherlands
- Michael Mungoma, Dean, School of Pharmacy Mount Kenya University PTAC Member - Kenya

This webinar will explore pharmacists’ frontline role in reducing medication-related harm through medicines use review (MUR). Pharmacists from different care settings from across the world will discuss how MUR has been integrated into their clinical practice in addition to the evidence for the clinical and economic benefits supporting this service. Finally, the FIP toolkit on MUR, launched in December 2020, will be presented.
• Define Medicines Use Review (MUR) and discuss the clinical and economic evidence supporting its implementation
• Explore examples of MUR practices from different regions
• Become familiar with the FIP MUR toolkit to support the advocacy and establishment of the service

Moderator:
- Marja Airaksinen, Chair of the FIP Working Group on Patient Safety - Finland

Panellists:
- Filipa Alves da Costa, Assistant Professor University of Lisbon - Portugal
- Nai-Hwa Mei, Clinical Pharmacist Specialist
Department of Pharmacy, Shin Kong Wu Ho-Su Memorial Hospital - China Taiwan
- Matthew Hung, Clinical Staff Pharmacist St. Mary’s Hospital, Montreal West Island Integrated University Health and Social Services Centre Practice Development Projects Assistant (consultancy) - Canada

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. The Programme aims to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

The 2nd episode of the FIP “Setting goals for the decade ahead” programme explores FIP Development Goal 18: Access to medicines, devices and services. Through this goal, we aim to optimise access to effective and innovative medicines, medical devices and pharmaceutical care through frameworks, education and training. Together we will showcase the importance of access to medicines, devices and services as a means to attaining better health for all.

Event outcomes:
1. Describe the FIP Development Goals and explain the components of DG 18 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 18 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 18
4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

Moderator:
Marwan Akel, FIP Projects Manager – Workforce FIP, Lebanon
Co-moderator:
Desak Ernawati, FIP Global Lead for DG4 Advanced practice & specialisation, Indonesia

Panellists:
- Bärbel Holbein, FIP Global Lead for DG7 Advancing integrated services, Germany
- Ema Paulino, FIP Professional Secretary- Portugal
- Giovanni Pauletti, Associate Dean & Pfeiffer Chair University of Health Sciences and Pharmacy in St. Louis -USA

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals.

Online delivery of goods became very common nowadays, and even increased during COVID-19 pandemic and related lockdowns. The way consumers obtain medicines, as special type of goods, is also changing. In some countries, buying medicines online is becoming common practice, because buyers are preferring to order their medicines through a click of a button rather than taking a trip to a pharmacy or a drug store. However, online customers may have difficulty knowing whether an Internet pharmacy is a legitimate operation, without the same confidence as they would have had in the neighborhood pharmacy. What are the practices in place to make sure that the online patient or customer can rely that they will receive the medicine they need? What are the advantages and disadvantages to accessing medicines on-line from patients, as well as from pharmacists’ point of view? Since medicines are regulated products and the need for consideration of ethical issues in access to medicines is important, the online pharmacy services have both advantages and disadvantages. What are the medicines patients are allowed to receive online in different countries? What is the scope of online pharmaceutical services vis-à-vis medicine procurement, distribution, online prescriptions, internet drug information, pharmaceutical care services, etc.?

Chair:
- Sari Westermarck, Owner-Proprietary pharmacist, Vihti 1. Pharmacy - Finland

Panellists:
- Manjiri Gharat, FIP Vice-President, FIP - India
- Filipa Alves da Costa, Assistant Professor, University of Lisbon - Portugal
- John Hertig, Board President Alliance for Safe Online Pharmacies - USA

For a young and early career pharmacist or pharmaceutical scientist, choosing the right career is no easy feat. Not only are the options too numerous for one to choose sometimes, they can also seem quite few, depending on one’s exposure. Notwithstanding, the path to each career requires intricate and timely preparation to gain the required expertise.

This FIP YPG webinar seeks to introduce young pharmacists and pharmaceutical scientists to the Career development cycle and how it can effectively be used as a tool for professional development. Each speaker will cover fundamental insights with practical examples from their personal and professional experience with an aim to equip attendees with personalized and strategic leads for their effective career evolution.

The learning outcomes include:
1. Attendees will gain insights about the steps in the career development cycle.
2. Attendees will understand how to effectively utilize the continuing professional development cycle (Reflection, Planning, Action and Evaluation).
3. Attendees will learn about effective reflection and subsequent planning as a tool for continuing professional development
4. Attendees will gain knowledge on how properly carry out the evaluation process after taking appropriate action as it relates to career development.

Chair:
- Ikwaibom Umoiyoho, Hospital Pharmacist, Zenith Medical and Kidney Centre - Nigeria

Moderator:
- Ravi Sharma, Director of England, Royal Pharmaceutical Society - United Kingdom

Panellists:
- Anisha Sandhu, Lecturer, Monash University - Malaysia
- Arit Udoh, Global Lead FIP DG4/ Senior Clinical Project Manager, University of Birmingham - United Kingdom
- Toyin Tofade, Dean and Professor, Howard University College of Pharmacy - United States of America

Topics to address:
• Technology, which was first developed to facilitate communication, has now grown into a global network of computer systems that link multiple platforms and create interrelationships between governments, academic institutions, businesses and consumers.
• Implementing healthcare based on information system and technologies (e.g. e-health) had been proposed as a way to improve health services. Hence, the scope of pharmacy practice has expanded to the provision of pharmaceutical services via the internet.
• This session will outline some of the questions around the strengths and weaknesses of the online pharmacies, their threats, but also opportunities for e-pharmacy in the future.
• Some of the largest global e-commerce companies have shown that they have a robust supply chain to really disrupt the existing pharmaceutical supply chain. Pharmacists have responded with concern to these giants’ move into the pharmacy and e-pharmacy market. How can pharmacists take advantage of modern online marketplaces? Does face-to-face interaction with the patient still make a difference? What is the added value of online pharmaceutical care services compared to other e-commerce places?

Chair:
- Manjiri Gharat, Vice-President, FIP - India

Panellists:
- Jaime Acosta, Community Pharmacy Section’s Executive Committee Member, FIP CPS - Spain
- Ardalan Mirzaei, x, The University of Sydney - Australia
- Ukamaka Okafor, Director, Education and Training; Coordinator of Supply Chain and Logistics Project Management Unit, Pharmacists Council Nigeria - Nigeria

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. The Programme aims to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

The 1^st episode of the Programme focuses on a goal that impacts us all. FIP Development Goal 10 Equity & Equality calls for clear strategies to address inequalities in the pharmaceutical workforce, widen access and equity of pharmaceutical care services & access, as well equity in global capacity in pharmaceutical sciences development. In addition to meeting the event outcomes outlined below, this series opener will also feature special launches from FIP:

- A new digital FIP-EquityRx Collection “Inequities unmasked”

- An exclusive release of a global statement on vaccine equity

- A first look at a new resourceful online site for FIP-EquityRx, FIP’s programme on Equity & Equality in pharmacy

Event outcomes:

1. Describe the FIP Development Goals and explain the components of DG 10 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 10 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 10
4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project

Generic drugs provide significant public health benefits by providing high-quality, more affordable alternatives to brand name drugs. Approximately 90 percent of prescriptions dispensed in the United States are generic drugs that often are the product of an intricate global supply chain. The Office of Generic Drugs (OGD) is involved in
efforts to advance the international harmonization of scientific, technical and regulatory standards for generic drug development. The outcome of these global efforts is reduced time and cost of product development, consequently improving patient access to more affordable medicines. FDA’s efforts at international harmonization of standards for generic drugs will be reviewed. The financial impact of this harmonization on development costs and consequent easier access for patients to generic drugs will be discussed. The harmonization efforts would help regulatory agencies in the timely approval of generic drugs thereby accelerating access to affordable, safe, effective, and high-quality generic medicines for the American public.

Learning Objectives:
- Financial impact of harmonized international standards on global access to less expensive medications
- FDA’s operational modalities for generic drug approvals
- FDA’s efforts at international harmonization of scientific, technical and regulatory standards

Moderator:
- Mathew Cherian, ExCo Member, Industrial Pharmacy Section, FIP -

Panellists:
- Sarah Ibrahim, Associate Director, FDA, Center for Drug Evaluation and Research (CDER) - USA

What to do next? is a question many young, aspiring pharmaceutical scientists ask themselves as they progress in their education or early on in their careers. This webinar aims to inspire participants that are considering an academic career by showcasing two pharmaceutical researchers who have chosen an academic career. The speakers will reveal what was their motivation and how they navigated to their current position, what from their education was most valuable to their current career, and what experiences they have gained along the way.

Learning objectives:
- Participants will be able to compare an academic career in two different regions.
- Participants will learn what was required for the two speakers to reach their current role and use this to plan their own career.
- Participants will gain insights from the speakers on how to design/fulfill the key steps that make an early career researcher stand out.

Moderators:
- Sifei Han, NHMRC Early Career Fellow, Drug Delivery Disposition & Dynamics, Monash University - Australia
- Sarah Dineen-Griffin, Lecturer, Health Services Management, School of Biomedical Sciences, Charles Sturt University - Australia
- Khalid Garba Mohammed, Department of Pharmaceutics and Pharmaceutical Technology, Bayero University - Nigeria

Panellists:
- Stephanie Reuter Lange, Cancer Council Mid Career Research Fellow, University of South Australia - Australia
- Lirui Wang, Professor, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University - China

What to do next? is a question many young, aspiring pharmaceutical scientists ask themselves as they progress in their education or early on in their careers. This webinar aims to inspire participants that are considering a career in industry by showcasing two pharmaceutical researchers working in the pharmaceutical industry. The speakers will reveal what motivated their career choices, provide their best tips for securing a position in industry, and what opportunities they see in the future.

This event aligns with FIP Development Goals 2 and 9.

Learning Objectives:

- Participants will be able to compare a career in two different pharmaceutical companies.
- Participants will learn what was required for the two speakers to reach their current role and use this to plan their own career.
- Participants will gain insights from the speakers on how to design/fulfil the key steps that make an early career researcher stand out.

Moderators:
- Dr Khalid Garba Mohammed, Department of Pharmaceutics and Pharmaceutical Technology, Bayero University - Nigeria
- Dr Rebecka Isaksson, Postdoctoral Research Associate, Department of Chemistry, University College London - UK

Panellists:
- Dr Tim Foley, DNA-Encoded Library Selection & Primary Pharmacology Lab Head, Pfizer - US
- Ms Shivani Baldeo, Retail Strategy and Innovation Lead African Cluster,
AstraZeneca - South Africa

After the COVID-19 pandemic, current and future pharmacy education needs to be improved to strengthen the pharmacy profession. With the demand for higher education increasing, enrolment strategies are becoming more critical to pharmacy institutions. From attracting and recruiting of students, through career development after graduation, the development of new strategies is required to support the future of pharmacy schools around the world.

Learning Objectives:
- Defining key areas of challenge in pharmacy education regarding prospective students, including attracting, training, developing and leading them
- Contributing to motivation and professional development to ensure career progression for pharmacy graduates
- Careful planning to address short term needs in pharmacy education while ensuring support for the future of pharmacy schools around the world in the long term
- Identifying new ways to develop the pharmacy profession such that it is strengthened and continuously improves

Moderator:
- Carlo Marra , Dean, School of Pharmacy University of Otago - New Zealand

Facilitator:
- Ozge Ozer, FIP Educational Partnership Coordinator, FIP - Turkey

Panellists:
- Dalal Al-Taweel, Vice Dean of Academic and Student Affairs, Faculty of Pharmacy, Kuwait University - Kuwait
- Rosana Isabel dos Santos, Professor, Federal University of Santa Catarina - Brazil
- Toyin Tofade, Dean and Professor, Howard University College of Pharmacy - USA
- Karima Bennara, Chairperson of Pharmacy Education Committee, IPSF - Algeria
- Louisa Sullivan, Clinical Pharmacist, University of Washington Medical Center - USA

FIP’s Regulators’ Forum will present a new regulatory vaccination preparedness self-assessment tool and risk assessment. Foundational regulatory needs will be presented to ensure oversight, quality assurance and public protection as the scope of pharmacist’s patient care is expanded to include prescribing, vaccination and testing in order to address population health needs during a pandemic. A brief overview of the data collected by FIP on the role of pharmacists in vaccinations and other FIP documents will also be presented.

Learning Objectives:
- Awareness of the global variation of the pharmacist scope of practice reported FIP global survey
- The valuable and available resource of information contained in the FIP documents regarding pharmacist vaccination and expanded scope of practice.
- Foundational regulatory needs for public protection when expanding the pharmacists’ scope of practice.
- Availability of a vaccination preparedness self-assessment tool.

Moderators:
- Ronald Guse, Chair, FIP Regulators Forum - Canada
- Catherine Duggan, CEO, FIP - The Netherlands

Panellists:
- Gonçalo Sousa Pinto, Lead for Practice Development and Transformation, FIP - The Netherlands
- Lemrey “Al” Carter, Executive Director, National Association of Boards of Pharmacy - USA

This webinar will provide an educational programme to support hospital pharmacists in developing preceptor skills, especially with regards to currently trending areas in pharmacy education. Furthermore, commonly encountered challenges and potential solutions to address them will be presented.

At the end of this webinar, attendees will be able to:

- Utilise skills and strategies to effectively precept students, residents, and interns in the hospital setting
- Incorporate preceptor skills with regards to currently trending areas in pharmacy education
- Address commonly encountered challenges as a preceptor using different potential solutions

Moderator:
- Marianne F. Ivey, Professor Emerita, Pharmacy Practice & Administrative Services, University of Cincinnati - USA

Speakers:
- Phuoc Anne Nguyen, Pharmacy Manager, Houston Methodist West Hospital - USA
- Salwa Ahsan, Chief of Pharmacy, Shifa International Hospitals Ltd. - Pakistan
- Matthew Hung, Clinical Staff Pharmacist, St. Mary’s Hospital, Montreal West Island Integrated University Health and Social Services Centre - Canada

The ‘’FIP digital health in pharmacy education’’ report describes the readiness, adaptability, and responsiveness of pharmacy education to train current and future pharmaceutical workforce on digital health as well as knowledge and skill gaps of the pharmaceutical workforce to respond to the technological transformation. The launch event will showcase key findings from the ‘’FIP digital health in pharmacy education’’ survey, describe good practices on digital health education initiatives and a panel will be conducted to identify a roadmap for digital health education. Participants will have an opportunity to take part in a live simulation of a digital health education solution!

Learning Objectives:

- Learn about the key findings from the FIP Digital health in pharmacy education survey;
- Explore good practices on course descriptions, examples of assignments and learning activities on digital health,
- Identify areas of development for the long-term vision of digital health in pharmaceutical practice, science and education

Moderator:
- Aukje Mantel-Teeuwisse, Utrecht University School of Pharmacy - The Netherlands

Facilitator&Speakers:
- Nilhan Uzman, FIP - The Netherlands
- Sherly Meilianti, University College London - UK
- Bidhata Khatri, FIP - India

Speakers:
- Jaime Acosta Gomez, Farmacia Acosta - Spain
- Claudia Rijcken, Pharmi - The Netherlands
- Timothy Aungst, Massachusetts College of Pharmacy and Health Sciences - USA
- Lilian Azzopardi, University of Malta - Malta
- Karima Bennara, University of Batna - Algeria
- Whitley Yi, Well Dot Inc - USA
- Sara Ramadan, PharmaVgate Academy - UAE
- Catherine Duggan, FIP - The Netherlands
- Jacqueline Surugue, FIP - France
- Ema Paulino, FIP - Portugal
- Giovanni Pauletti, University of Health Sciences & Pharmacy in St. Louis - USA
- Ralph Altiere, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences - USA

This online seminar will give an introduction to the MCS concept for the development of oral solid dosage forms (tablets and capsules). It will give case studies of its application throughout the drug development process in the areas of formulation design, process development, materials science and characterization of both API and drug product. There will be opportunity for discussion around the path forward for the MCS initiative, as well as barriers seen to future implementation.

Delegates will learn the principles of the MCS concept and how to apply it to both batch and continuous manufacture. Examples will be given of how MCS can be combined with modelling to improve drug development.

This event is organised by the Academy of Pharmaceutical Scientists (APS), the FIP Drug Delivery and Manufacturing Special Interest Group and the Board of Pharmaceutical Sciences of FIP.

Moderator:
- Michael Leane, Associate Scientific Director, Bristol Myers Squibb - UK
- Tetsuya Ozeki, Chair for SIG on Drug Delivery and Manufacturing, International Pharmaceutical Federation (FIP) - Japan

Speaker:
- Kendal Pitt, Senior Technical Director, GlaxoSmithKline - UK
- Iris Ziegler, Director Pharmaceutical Sciences & QbD, Corden Pharma International GmbH - Germany
- Gavin Reynolds, Astra Zeneca - UK
- Neil Dawson, Senior Principal Scientist, Pfizer - UK

This session will examine the application of the concepts of the Health Belief Model (HBM) which is one of the first and still most commonly used frameworks or theories of health behavior. There has been successful application of the HBM in health and wellness programs, including immunization and chronic diseases management. As such, the application of HBM will be illustrated in a flu awareness campaign that targeted Lebanese University students. Examples of improving immunization rates and addressing patient perceptions in an ambulatory care setting in the U.S. will also be discussed.

Additionally, this session will discuss the application of the Continuing Professional Development (CPD) model to train pharmacists with the knowledge and skills in emergency preparedness and response, including mass vaccination.

Learning Objectives

1. Examine successful health initiatives using the HBM. (AK)
2. Describe two vaccination campaigns and programs in different populations to address vaccine hesitancy and improve vaccinate rates for flu and COVID-19 vaccines. (NM and SS)
3. Apply the Continuing professional development (CPD) model for pharmacists and student pharmacists to have structured approach for preparing health promotion programs, including COVID-19 mass vaccination.

Moderator:

- Naoko Arakawa, Assistant Professor in International Pharmacy, University of Nottingham - UK

Panellists:

- Abby Kahaleh, Tenured Associate Professor for Clinical and Administrative Sciences; Board of Trustees Faculty, Roosevelt University - USA
- Nisreen Mourad, Clinical Associate Professor, Lebanese International University - Lebanon
- See-Won Seo, Assistant Professor and Clinical Pharmacist, Albany College of Pharmacy and Health Sciences - USA
- Hoai-An Truong, Professor and Director of Public Health, University of Maryland Eastern Shore - USA

The objective of this webinar is to provide an overview of the research steps and methods involved in Pharmacy Practice Research. The webinar will start with a discussion on how to plan and execute a research idea, and the steps involved in this process. Research methods and approaches used in pharmacy practice research will be discussed. The webinar will provide insights on how to successfully write and publish a scientific paper from an editor’s perspective.

Finally a young researcher will share her ideas on her journey as a researcher – and what learnings she can share based on this.

• To introduce the relevance of qualitative methods in Pharmacy Practice Research
• To introduce the relevance of quantitative methods in Pharmacy Practice Research
• To give recommendations on publishing Pharmacy Practice Research
• To share learnings from a research journey, from novel researcher to established researcher

Chair:
- Fernanda Stumpf Tonin, HEOR consultant, Federal University of Paraná - Brazil

Speakers:
- Lotte Stig Noeagaard, Associate professor, University of Copenhagen - Denmark
- Marcel Bouvy, Professor of Pharmaceutical Care, Utrecht University - The Netherlands
- Shane P. Desselle, Professor of Social and Behavioral Pharmacy, Touro University California - USA
- Kaitlyn Watson, Post Doc, University of Alberta - Canada

Although pharmacists have administered vaccines in several countries for years, this role is still new or even unknown to the profession in many parts of the world. As a role that involves direct contact with the patient and the administration of a product by injection, it may still generate some concerns among pharmacists with regards to the administration procedure, common errors and the management of anaphylactic reactions. This webinar will describe such procedures and address common questions and concerns.

After this webinar the participants should have a better understanding of the following topics:

- Vaccine administration routes and procedures.
- Common errors that may be committed during vaccine administration and how to avoid them.
- Prevention and management of adverse reactions, including anaphylactic shock.

Moderator:

- Marwan Akel, Chairperson Pharmacy Practice Department, Lebanese International University - Lebanon

Panellists:

- Lisa Nissen, Professor and Head of the School of Clinical Sciences, Queensland University of Technology - Australia
- Maria Mendes, Area Manager at the Centre for Medicines Information & Health Interventions (CEDIME) at the National Association of Pharmacies - Portugal

This global virtual Summit – the programme finale – is a high-level event in which we will recap the primary outcomes of the 24-event digital series. Together, we will adopt the FIP Commitment to Action on Vaccination in Pharmacy which will be launched during the Summit. Global leaders from health and pharmacy join this landmark event.

This roundtable event follows 6 regional events – episodes 3.1 to 3.6 of the programme – which dissected priorties, needs and barriers across the world’s six regions. We now bring back the key outcomes from the six regional discussions int one roundtable to identify common priorities for action to transform vaccination. Each regional perspective will be represented by the panelists, alongside other leaders and stakeholders.

Objective
To understand the commonalities of different jurisdictions in delivering on the Transformation of Vaccination Globally and Regionally

Moderator:
- Ronald Guse, Chair, FIP Regulators' Forum, National Association of Boards of Pharmacy, Canadian Consultant - Canada

Co-moderator:
- Lina Bader, Lead for Workforce Transformation & Development, Programme Lead – Transforming Vaccination Globally & Regionally, International Pharmaceutical Federation (FIP) - Saudi Arabia

Speakers:
- Stephanie Kohl, Policy & Advocacy Officer, European Association of Hospital Pharmacists - Belgium
- G. Sumalatha, Executive Committee Member, SEARPharm Forum - India
- Nadia Al Mazrouei, President, EMROPharm Forum, Academic &Healthcare consultant - UAE
- Prosper Hiag, President, African Pharmaceutical Forum - Cameroon
- John Jackson, President, Western Pacific Pharmaceutical Forum - Australia
- Eduardo Savio, President, Pharmaceutical Forum of the Americas - Uruguay

The 2019 FIP YPG Needs Assessment survey found that early career pharmacists and pharmaceutical scientists who responded to the survey expressed a need for career development resources. It was proposed that a ready-made resource would be beneficial to provide sufficient guidance to pharmacists and pharmaceutical scientists who are in the early phase of their careers.

The Career Development Toolkit for Early Career Pharmacists and Pharmaceutical Scientists aims to be a guide for career development and building expertise in pharmacy and pharmaceutical sciences. The Toolkit was developed in 2020 and will be launched and presented extensively in this event to promote the Toolkit and encourage its wider dissemination

Moderator:
Shepard Nqobile Mhlaba- Global Lead, FIP Workforce Development Hub, WDG2 (Zimbabwe)

Co-moderator and Speaker:
Ayodeji Matuluko- FIP YPG Chairperson of Projects 2020/Project lead FIP YPG Career Development Toolkit (Nigeria)

Speakers/Panelists
1. Sherly Meilianti- FIP YPG President 2020 (Indonesia)
2. Emmanuel Oluwagbade- FIP YPG Professional Development team 2020 (Nigeria)
3. Adam Pattison Rathbone- Lecturer in Clinical and Social Pharmacy, School of Pharmacy, Faculty of Medical Sciences, Newcastle University (UK)
4. Antria Pavlidou- Clinical Pharmacist, Pharmaceutical Services, Ministry of Health (Cyprus)
5. Aska Patel- Consultant Pharmacist, Central West Local Health Integration Network Acuvise Consultancy Inc (Canada)
6. Austin Green- PGY-1 Ambulatory Care/HIV Pharmacy Resident, UC Davis Health Sacramento, CA (USA)
7. Dimitrios Ilias-Balourdas- Academic Pharmacist /PhD Candidate, Goethe University - Structural Genomics Consortium, Frankfurt, Germany (Greece)
8. Funmbi Okoya- FIP YPG Chairperson of Public Relations 2020 (Nigeria)
9. Gizem Gulpinar- Academic Pharmacist/Post-Doc Researcher, Ankara University (Turkey)
10. Karima Bennara- IPSF Chairperson of Pharmacy Education 2020-21 (Algeria)
11. Yoonjung Choi- Research Scientist, Korea Institute for Pharmaceutical Policy Affairs (Korea)

The Global COVID-19 impact on, consumer behavior/patient expectations, healthcare, and pharmacy workforce was noticeable.
The importance of pharmacy technicians in healthcare delivery pre-COVID-19, during crisis, and post-COVID-19 is crucial for the healthcare and patient services.
Pharmacy technicians from different work settings, community, hospital and pharmacy technicians’ association share their experiences with the public

Moderators:
Vijay Sarma, VP Pharmacy Marketing, McCann Health, Canada
Teri-Lynne Fogarty, Lecturer/ Coordinator of Pharmacy technician programme, Nelson Mandela University, South Africa

Speakers:
Isnarti Abu Aman, Pharmacy Technician Executive, Khoo Teck Puat Hospital, Singapore

Lorah Hickman, Senior Pharmacy Technician for Workforce and Development
Alfred Hospital, Australia

Birgitte Jeanette Andersen, Pharmaceutical consultant, Denmark

Mike Johnston, CEO, National Pharmacy Technician Association, USA

Event 3.6 focuses on the regional needs and drivers for transforming vaccination in the Americas region. This involves discussing the progress made in countries in the Americas with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation.

Moderator:
- Nuria Montero Chinchilla, Directora de Práctica Farmacéutica, Foro Farmacéutico de las Américas - Costa Rica
- Carlos Lacava, Vice-presidente, Federación Internacional Farmacéutica (FIP) - Uruguay

Facilitator:
- Gonçalo Sousa Pinto, Director de Desarrollo y Transformación de la Práctica, Federación Internacional Farmacéutica (FIP) - España

Speakers:
- Ligia Álvarez, Presidente, Colegio Nacional de Farmacéuticos - Panamá
- Maria Isabel Reinoso, Presidente, Confederacion Farmaceutica Argentina - Argentina
- Luis Baez, Presidente, Asociación de Químicos Farmacéuticos del Paraguay-AQUIMFARP - Paraguay
- Marco Oswaldo Padilla Puruncajas, Presidente, Colegio de Químicos, Bioquímicos y Farmacéuticos de Pichincha, Ecuador
- Mariela Méndez Ferreira, Presidente, Asociación de Química y Farmacia del Uruguay- Uruguay

In the fifth of six regions we dissect, event 3.5 focuses on the regional needs and drivers for transforming vaccination in the African region. This involves discussing the progress made in Africa with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from Africa join us for a true regional perspective.

Objective
To understand the African perspective in delivering on the Transformation of Vaccination Globally and Regionally

Moderators:
Prosper Hiag, President, African Pharmaceutical Forum (APF), Member of the Council of the FIP – Cameroon
Jacqueline Surugue, Vice President – International Pharmaceutical Federation (FIP)- Past President of the Hospital Section Chair of the FIP Pharmaceutical Technology Forum, Hospital Pharmacist, Centre Hospitalier Georges Renon – France

Facilitator:
Nilhan Uzman, Lead for Education Policy and Implementation, International Pharmaceutical Federation (FIP) – Turkey

Speakers:
Yvonne Yirenkyiwaa Esseku, Vice President, Pharmaceutical Society of Ghana – Ghana
Redouane Soualmi, General Secretary, Algerian Pharmaceutical Federation – Fédération Algérienne de Pharmacie – Algeria
Nahil Dave, Superintendent Pharmacist, Pharmaceutical Society of Kenya – Kenya

Qualification of dissolution apparatus

Dissolution testing is of outmost importance when characterizing pharmaceutical products with regards to their performance as well as their quality.
In order to ensure reliable dissolution results, using properly qualified instruments is crucial.
This presentation will go through the various possible qualification approaches with their Pros and Cons.

Learning objectives:
Understand the importance of instrument qualification
Identify the possible qualification strategies
Select and implement the most adapted qualification process

Moderator:
Horst-Dieter Friedel, Director, Bayer AG, Germany
FIP Chair Special Interest Group Regulatory Sciences and Quality

Speaker:
Samir Haddouchi, Managing Director, SPS Pharma Services, France
FIP focus group dissolution/drug release member

In the fourth of six regions we dissect, event 3.4 focuses on the regional needs and drivers for transforming vaccination in the Western Pacific. This involves discussing the progress made in Western Pacific countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the Western Pacific join us for a true regional perspective.

Objective
To understand the Western Pacific perspective in delivering on the Transformation of Vaccination Globally and Regionally

Moderators:
John Jackson, President, Western Pacific Pharmaceutical Forum – Australia
Parisa Aslani, Vice-President, International Pharmaceutical Federation (FIP) – Australia

Facilitator:
Gonçalo Sousa Pinto, Lead for Practice Development and Transformation, International Pharmaceutical Federation (FIP)

Speakers:
Gilda Sebua-Saljay, President, Philippine Pharmacists Association – Philippine
Peter Guthrey, Senior Pharmacist- Strategic Policy, Pharmaceutical Society of Australia – Australia
Scarlett Pong, President, The Pharmaceutical Society of Hong Kong (PSHK) – Hong Kong

The world’s pharmacy team is fighting COVID-19 in a variety of ways. This webinar will host stakeholders working in various pharmacy sectors and from different geographical regions to share examples and draw on what we can learn in our pursuit of resilience. Research-driven findings will be shared that may aid in developing and advancing resilience within ourselves, for our patients, colleagues and the systems we are a part in our ability to tackle very challenging times. This event is delivered by FIP in collaboration with GRiT – Global Resilience Team, Led by: Dr Karen Whitfield.

The webinar aims to:
- Introduce participants to GRiT - Global Resilience Team ethos; a collaborative team passionate for raising awareness of the importance of developing resilience in our workforce.
- Showcase global perspectives from research and practice related to resilience in pharmacy.
- Share experiences in developing relevant and practical material to build into pharmacy curricula.

Moderator:
- Prof. Zubin Austin, Koffler Research Chair in Management, Leslie Dan Faculty of Pharmacy and Institute for Health Policy, Management, and Evaluation - Faculty of Medicine at the University of Toronto - Canada

Event Chair:
- Dr Catriona Bradley, Executive Director, The Irish Institute of Pharmacy - Ireland

Panellists:
- Dr Karen Whitfield, Associate Professor, School of Pharmacy, The University of Queensland - Australia
- Dr Sarah Wills, Senior Lecturer, The University of Manchester - UK
- Dr Dalia Bajis, Assistant Professor, Mohammed Al-Mana College for Medical Sciences - Saudi Arabia
- Dr Kyle Wilby, Associate Dean (Undergraduate) and Associate Professor, School of Pharmacy, University of Otago - New Zealand
- Dr Vibhuti Arya, Global Lead, Equity and Equality, International Pharmaceutical Federation (FIP) - USA
- Elizabeth Shekalaghe, Registrar /CEO, Pharmacy Council Tanzania - Tanzania
- Catherine Duggan, CEO, International Pharmaceutical Federation (FIP) - The Netherlands

In the third of six regions we dissect, event 3.3 focuses on the regional needs and drivers for transforming vaccination in the Eastern Mediterranean region (EMR). This involves discussing the progress made in EMR countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the EMR join us for a true regional perspective.

Objective:
To understand the Eastern Mediterranean perspective in delivering on the Transformation of Vaccination Globally and Regionally

Funded by Charitable Donation from Pfizer

Moderators:
- Nadia Al Mazrouei, President, EMROPharm Forum - UAE
- Samira Shammas, Vice President, International Pharmaceutical Federation (FIP) - Jordan

Facilitator:
- Lina Bader, Lead for Workforce Transformation and Development, International Pharmaceutical Federation (FIP) - The Netherlands

Speakers:
- Ziad Nassour, President, Lebanese Order of Pharmacists - Lebanon
- Adi Al-Nuseirat, Technical Officer, WHO Eastern Mediterranean Regional Office - Egypt
- Zeid Kilani, President, Jordanian Pharmacists Association - Jordan
- Alaa Hayallah, President, Pharmacists Syndicate in Assiut - Egypt
- Faraz Ashraf, Deputy director pharmacy / Joint Secretary of Pakistan Pharmacists Association, The children's hospital and the institute of child health, Lahore - Pakistan
- Mohammed Al-Nuzili, Governing Board President, Yemen Community Pharmacy Syndicate - Yemen

In the second of six regions we dissect, event 3.2 focuses on the regional needs and drivers for transforming vaccination in the South East Asian region (SEAR). This involves discussing the progress made in SEAR countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the SEAR join us for a true regional perspective.

Objective:
To understand the South East Asian perspective in delivering on the Transformation of Vaccination Globally and Regionally

Funded by Charitable Donation from Pfizer

Moderators:
- G. Sumalatha, Executive Committee Member, SEARPharm Forum - India
- Ashok Soni, Vice President, International Pharmaceutical Federation (FIP) - UK

Facilitator:
- Lina Bader, Lead for Workforce Transformation and Development, International Pharmaceutical Federation (FIP) - The Netherlands

Speakers:
- Rao Vadlamudi, Immediate Past President, Indian Pharmaceutical Association (IPA) - India
- Lalith Senarathna, Senior Lecturer, Rajarata University of Sri Lanka - Sri Lanka
- Manisha Shridhar, Regional Advisor, WHO Regional Office for South-East Asia - India
- Kampanart Huanbutta, Assistant Dean, Faculty of Pharmacy, Burapha University - Thailand

In the first of six regions we dissect, event 3.1 focuses on the regional needs and drivers for transforming vaccination in Europe. This involves discussing the progress made in European countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the European region join us for a true regional perspective.

Objective:
To understand the European perspective in delivering on the Transformation of Vaccination Globally and Regionally

Funded by Charitable Donation from Pfizer

Moderators:
- Stephanie Kohl, Policy & Advocacy Officer, European Association of Hospital Pharmacists (EAHP) - Belgium
- Ema Paulino, Professional Secretary, International Pharmaceutical Federation (FIP) - Portugal

Facilitator:
- Lina Bader, Lead for Workforce Transformation and Development, International Pharmaceutical Federation (FIP) - The Netherlands

Speakers:
- Alain Delgutte, President-elect, Pharmaceutical Group of the European Union (PGEU) - Belgium
- Monika Derecque-Pois, Director General, European Healthcare Distribution Association (GIRP) - Belgium
- Mary Ann Sant Fournier, President, Malta Chamber of Pharmacists - Malta
- Niyazi Cakmak, Technical Officer, WHO Regional Office for Europe - Denmark
- Lieven Lieven Zwaenepoel, Past President, Belgian Pharmaceutical Association (APB) Belgium
- Mesut Sancar, Representative, Turkish Pharmacists' Association (TPA) - Turkey

This event will discuss how the quality, efficacy and safety of vaccines are built into their development and manufacturing processes, including the clinical research they undergo and the strict regulatory assessment that precedes their marketing authorization. In addition, speakers will discuss how to make such processes understood and well-known by the public in a transparent and clear manner, in order to build confidence in vaccines and address the grave problem of vaccine hesitancy and anti-vaccines movements, i.e., the refusal to get vaccinated despite the availability of vaccines.

Learning Objectives:
After this webinar the participants should have a better understanding of the following topics:
1. Vaccine quality and safety assurance.
2. Vaccine hesitancy and how to address it through transparent and evidence-based arguments, and positive examples of the value of vaccines.
3. The role of pharmacists in building vaccine confidence.

Programme: Communicating vaccine safety, building vaccine confidence
Moderator:
- Giovanni Pauletti, FIP’s Scientific Secretary
Chair, Department of Pharmaceutical & Administrative Sciences, St. Louis College of Pharmacy - USA

Speakers:
- Alberta Di Pasquale, Director, Global Medical Affairs Vaccine Science and Medical Education Lead, GSK - Belgium
- Rosario Cáceres, Community pharmacist, vaccines expert and vaccine confidence advocate, Royal Pharmaceutical College of Seville and Andalusian Council of Pharmacists – Spain

In this episode – “Setting Transformation Goals for Vaccination Globally” – is a roundtable discussion that focuses on the role of the FIP Development Goals in the transformation of pharmacist vaccination globally and regionally. The discussion will focus on the development of transformative goals and how these goals will be used to deliver pharmacist vaccinators in all jurisdictions, resulting in increased vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To summarise and discuss the impact of FIP Development Goals in the Transformation of Vaccination Globally and Regionally.

Moderators:
- Gonçalo Sousa Pinto, Lead for Practice Development and Transformation, International Pharmaceutical Federation - The Netherlands
- Carlene Ngoma, Global Lead for Equity and FIP Program co-ordinator for FIP transformation of Vaccination Globally and Regionally, International Pharmaceutical Federation - Australia

Speakers:
- Arit Udoh, Senior Clinical Project Manager, University of Birmingham - UK
- Marwan Akel, Chairperson Pharmacy Practice Department, Lebanese International University - Lebanon
- Chima Amadi, Education and Training Personnel, Pharmacists’ Council Nigeria - Nigeria
- Catherine Duggan, Chief Executive Officer, International Pharmaceutical Federation - The Netherlands
- Sabiha Essack, South African Research Chair in Antibiotic Resistance & One Health, University of KwaZulu-Natal - South Africa
- Lars-Åke Söderlund, President the Community Pharmacy Section, International Pharmaceutical Federation - Sweden

Aim
To describe an evidence-based approach to self-care of mild COVID-19 symptoms

Learning Objectives:
• Describe approaches for preventing the spread of COVID-19
• List symptoms of COVID-19 – similarities and differences to influenza;
• Identify myths associated with self-care of COVID-19.
• Describe how mild symptoms such as fever and pain should be managed;
• Discuss when to refer more serious cases (escalating care in COVID-19).

Target audience – all those involved in the primary health care response to the coronavirus pandemic

Programme:
1. Welcome – Moderator Gonçalo Sousa Pinto, FIP Lead for Practice Development and Transformation

2. COVID-19: preventing its spread and understanding its symptoms – Jaime Acosta-Gómez, Community Pharmacist and Pharmacy Owner, Spain

3. Dispelling myths about self-care treatments of COVID-19 – Christopher John, FIP Lead for Data and Intelligence

4. How to manage mild symptoms – self-care case study. Lars-Åke Söderlund, President FIP Community Pharmacy Section

5. Panel Discussion – questions and answers – All speakers

Obstetric patients present a unique challenge in medicine as these patients cannot be treated as a “normal” adult due to changes in pharmacokinetic and pharmacodynamic properties. Additionally, there are specific disease states that only impact the obstetric population. The goal of this webinar is to explore the role that pharmacists can have in caring for obstetric patients. In addition to describing published literature, the speakers will share information about their own personal experiences working alongside the multidisciplinary team caring for this niche population.

Explain clinical pharmacy services in obstetrics

Summarize literature supporting clinical pharmacy services in obstetrics

Relate personal experiences with pharmacists in the obstetrics setting

FIP Boards, Sections, SIGs, group and/or external partners involved in the planning and delivery. These groups and their logos will be used for marketing purposes.

Moderator:
Noelle Leung, Maternal Fetal Medicine and Obstetrics Clinical Pharmacist, University of Kentucky Health Care - USA

Speakers:
Lauren Leader, Clinical Pharmacist Specialist - Obstetrics and Gynecology Michigan Medicine | University of Michigan College of Pharmacy - USA
Camila Rios, Pharmaceutical Coordinator Hospital de Alta Complejidad - Argentina
Molly Stout, Division Chief, Maternal Fetal Medicine, Michigan Medicine - USA

The COVID-19 pandemic has created an urgent need for diagnostic testing of patients and populations. In response, a multitude of COVID-19 tests are available to use from many different manufacturers and organisations. FIP has created a counselling information guide to assist practising pharmacists around the world in talking to patients who have questions concerning COVID-19 tests. This joint FIP-ASHP online event will present the newly developed guidance on Evaluation of Diagnostic Testing & Methods, as well as tools for pharmacists developed by the American Society of Health-System Pharmacists (ASHP). Panellists will discuss issues about care and how to manage the risks with evidence is the focus.

Moderator:
Zuzana Kusynova, Lead for Policy, Practice and Compliance, FIP, Netherlands

Panellist:
Mary Ann Kliethermes, Director, Medication Safety and Quality, American Society of Health-System Pharmacists (ASHP), USA

Catherine Duggan, CEO, FIP, Netherlands

Julien Fonsart, Senior specialist in laboratory medicine pharmacist, Hôpital Lariboisière, Université de Paris, France

Ally Dering-Anderson, Clinical Associate Professor in the Department of Pharmacy Practice & Science, University of Nebraska College of Pharmacy, USA

Margaret Underwood, Pharmacy student & FIP Intern, FIP, USA

Jasminka N Sarunac, Lead Pharmacist Investigational drugs/Clinical trial, Pharmacoepidemiologist, John Hunter Hospital, Australia

In this episode – “Pharmacist Vaccinators and Patient Safety” – is an interview format that focuses on the FIP Development Goal 19: Patient Safety from the perspective of vaccination by a pharmacist. The role of pharmacists in delivering safe vaccinations; participation in vaccination monitoring and adverse event reporting, and the role of improving vaccination rates as a method of reducing overall harm caused by preventable disease.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 19: Patient Safety in the Transformation of Vaccination Globally and Regionally

Moderator:
Lars-Åke Söderlund, Executive Advisor, Apoteket AB - Sweden

Speakers:
Ramesh Walpola, Lecturer, School of Population Health, UNSW Sydney - Australia
John Hertig, Associate Professor, Butler University - USA
Ema Paulino, Professional Secretary, International Pharmaceutical Federation (FIP) - Portugal
Alpana Mair, Head of Prescribing and Therapeutics for Scottish Government, coordinating delivery of Governments work programme and advising Ministers on Quality, safety and effectiveness of Prescribing, Scottish Government - UK

In this episode – “Pharmacist Vaccinators as a way to improve access to medicines” – is an interview format that focuses on the FIP Development Goal 18: Access to Medicines and Services from the perspective of vaccination by a pharmacist. The role of pharmacists in ensuring that vaccinations are widely and easily accessible by all people in all areas of the world, and the expertise of pharmacists in delivering the logistics and services needed to increase vaccination rates.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 18: Access to Medicines and Services in the Transformation of Vaccination Globally and Regionally

Moderator:
Catherine Duggan, CEO, International Pharmaceutical Federation (FIP) - UK

Panellists:
Jane Barratt, Secretary General, International Federation on Ageing - Canada
Alexandra Ruth, Doctoral Student, Johns Hopkins Bloomberg School of Public Health - USA

The purpose of this webinar is to raise awareness and introduce the topics and format of the survey, its purpose and its alignment with the FIP Development Goals. This webinar will give you the opportunity to raise any questions about the survey and how the data it will produce may be of value to your organisation.

Programme

- Catherine Duggan - Introduction
- Chris John - GPO and alignment of this survey with FIP DGs
- Gonçalo Sousa Pinto - Community pharmacy regulation and access to professional services in the community, remuneration models
- Jaime Acosta - Online pharmacy operations, patient safety and quality use of medicines
- Q&A

Se generó, durante esta pandemia, diversos tipos de evidencia respecto a los tratamientos para la Covid-19 pero aún así, el farmacéutico se enfrenta a la necesidad de tomar decisiones en ausencia de evidencia científica. Para apoyar la toma de decisiones, se compartirán los caminos emprendidos en el Hospital G. Marañón para la selección y protocolización del tratamiento para Covid-19 mostrando las herramientas utilizadas. La segunda parte será dedicada a los sistemas de farmacovigilancia (FV) sostenibles. La FV no es una actividad de lujo sino que es la base del uso seguro de medicamentos. Involucrar al paciente. Uso off-label de medicamentos.

1. Identificar los principales retos en la selección y protocolización de los tratamientos para Covid-19 en un contexto de falta de evidencia científica.
2. Analizar rol de las agencias reguladoras, la Comisión de Farmacia y Terapéutica del hospital, el grupo de expertos Covid-19 y grupo PROA del hospital y el farmacéutico en enfermedades infecciosas.
3. Compartir la experiencia en el abordaje de la selección y protocolización del tratamiento para Covid-19.
4. Discutir estrategias para organizar sistemas sostenibles para la gestión de riesgos de productos farmacéuticos y dispositivos médicos en la farmacia hospitalaria post-Covid.

Moderadora:
Nora Gerpe, Química Farmacéutica Asociación de Química y Farmacia del Uruguay-Uruguay

Panelistas:
Carmen Rodriguez, Farmacéutica Hospitalaria Hospital General Universitario Gregorio Marañón - España
Lucila Castro Pastrana, Full Professor Universidad de las Américas, Puebla - México

In this episode – “Pharmacist Vaccinators and Antimicrobial Stewardship” – is an interview format that focuses on the FIP Development Goal 17: Antimicrobial Stewardship from the perspective of vaccination by a pharmacist. The role of vaccination in antimicrobial stewardship, preserving antimicrobial effectiveness, preventing antimicrobial resistance, and the promise of addressing these issues that pharmacists vaccinators will deliver.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 17: Antimicrobial Stewardship in the Transformation of Vaccination Globally and Regionally

Moderator:
Sabiha Essack, South African Research Chair in Antibiotic Resistance & One Health Chair: Global Respiratory Infection Partnership, University of KwaZulu-Natal - South Africa

Speakers:
Alfonso Pereira Céspedes, Pharmacist, University of Costa Rica - Costa Rica
Manjiri Gharat, Vice President, Indian Pharmaceutical Association - India
Philip Howard, Consultant Pharmacist, Leeds Teaching Hospitals NHS Trust - UK
Debra Goff, The Ohio State University Medical Center - USA

In this episode – “Pharmacist Vaccinators and Communicable Disease Management” – is an interview format that focuses on the FIP Development Goal 16: communicable and Vector Diseases from the perspective of vaccination by a pharmacist. The role of vaccination in the prevention and suppression of communicable and vector-borne disease, and the promise of addressing these diseases that pharmacists vaccinators will deliver.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 16: Communicable and Vector Diseases in the Transformation of Vaccination Globally and Regionally

Interviewer:
Catherine Duggan, CEO, International Pharmaceutical Federation (FIP) - UK

Interviewee:
Michael Klepser, Past President - Society of Infectious Diseases Pharmacists; Professor of Pharmacy Practice, Ferris State University - USA

The Global COVID impact on, consumer behavior/patient expectations, healthcare, and Pharmacy workforce was noticeable.
The Importance of pharmacy technicians in healthcare delivery pre-covid, during crisis, and post-covid is crucial for the healthcare and patient services.

Learning objectives:
Understand the global/healthcare/pharmacy landscape in a time of crisis;
Learn about the impact of the evolving role of Pharmacy Technicians on patients during COVID and beyond;
Illustrate exemplars of pharmacy technicians as change agents in 3 global regions and practice environments;
Translate global best practices to overcome barriers to change and identify how to evolve the pharmacy technician role to best serve patient outcomes in your practice setting.

Moderator:
Vijay Sarma, VP Pharmacy Marketing McCann Health - Canada

Panellists:
1. Cathy Schuster, Coordinator of Pharmacy Technicians programs Canadian Council for Accreditation of Pharmacy Programs - Canada
2. Kate Thorndike, Specialist Transplant Pharmacy Technician Addenbrookes Hospital - UK
3. Nyanje Samuel, Academic Pharmacy Technician Moi Teaching and Referral Hospital Kenya Medical Training College - Kenya
4. Clara Wong, Registered Pharmacy Technician Centennial College - Pharmacy Technician Program University of Toronto – Faculty of Pharmacy - Canada

In this episode, “Removing Policy Barriers to Pharmacist Vaccination” – is an interview format that focuses on the FIP Development Goal 13: Policy Development from the perspective of vaccination by a pharmacist. We discuss the process of policy development, identification of barriers, and engagement with stakeholders to ensure that pharmacist vaccination is accessible to all people in all settings where pharmacists work.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Outcomes
To understand the impact of FIP Development Goal 13: Policy Development in the Transformation of Vaccination Globally and Regionally

Moderators:
Ellen Schafheutle, Professor of Pharmacy Policy and Practice Centre for Pharmacy Workforce Studies, The University of Manchester - United Kingdom
Chima Amadi, Education and Training Personnel Pharmacists’ Council Nigeria - Nigeria

Panellists:
1. Walter da Silva João, President Brazilian Federal Council of Pharmacy - Brazil
2. Howard Rice, Hon. President & International Liaison Officer Pharmaceutical Association of Israel - Israel
3. Shane Jackson, Community and Consultant Pharmacist - Pharmaceutical Society of Australia - Australia

The objective of this webinar is to present a summary of the most innovative research in pharmacy practice and to discuss its contribution to the pharmacy profession.

Four key speakers from Research in Social and Administrative Pharmacy will present their research in the webinar. The topics covered will involve pharmacists prescribing, implementation of professional pharmacy services, roles of pharmacists during the COVID-19 pandemic and innovative models for pharmacists providing medication reviews.

The potential audience for this webinar will be practitioners with an interest in pharmacy practice research, novel and experienced researchers.

Learning objectives:
To identify how pharmacy practice research can contribute to the practice of pharmacy
To discuss how research can inform innovate pharmacy models of care
To discuss pharmacy practice research priority areas
FIP Organizers and/or external partners

Moderator:
Victoria Garcia Cardenas, Senior Lecturer University of Technology Sydney Research in Social and Administrative Pharmacy - Australia

Panellists:
1. Shane Desselle, Professor, Editor in Chief Touro University Research in Social and Administrative Pharmacy - USA
2. Karen Luetsch, Lecturer the University of Queensland - Australia
3. Carolina Ung, Professor University of Macau - China
4. Derek Stewart, Professor of Clinical Pharmacy and Practice - Qatar University - Qatar
5. Sherilyn Houle, Professor University of Waterloo - Canada

In this episode, “Empowering Pharmacists to Deliver Vaccination in all Settings” – is an interview format that focuses on the FIP Development Goal 7: Advanced Integrated Services from the perspective of vaccination by pharmacist. We discuss change management principles in the context of integrating advanced practice services into every day practice, ensuring that vaccination by pharmacists in all settings and jurisdictions is consistent with best evidence and practice guidelines. Where a pharmacist is present in all settings, vaccinations can be provided. Ensuring collaborative work and shared documentation with all healthcare professionals to ensure it is an integrated service.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Objective
Identifying mechanisms for transforming vaccination using FIP DG7: Advancing integrated services

Moderator:
Marwan Akel, Chairperson Pharmacy Practice Department Lebanese International University - Lebanon

Panellists:
1.Barbel Holbein, Lecturer and Researcher University of Bremen; University of applied sciences-Baden Württemberg - Germany
2.Sofía Segura, Professor University of Costa Rica and College of Pharmacists of Costa Rica - Costa Rica
3. Pamela Logan, Director of Pharmacy Services Irish Pharmacy Union - Ireland
4. Scarlett Pong, President of The Pharmaceutical Society of Hong Kong - Hong Kong

In this episode – “Vaccination: From Specialist Practice to Everyday Practice” – is an interview format that focuses on the FIP Development Goal 4: Advanced & Specialist Development from the perspective of vaccination by a pharmacist. We discuss the process required to take vaccination by pharmacists from a specialized field that few pharmacists deliver in some jurisdictions, to a standard part of pharmacists’ care in all settings and locations.

Power Point slides

Moderators:
Arit Udoh, Clinical Project Manager University of Birmingham-United Kingdom
Desak Ketut Ernawati, Academic and Researcher Faculty of Medicine Universitas Udayana-Indonesia

Speakers:
1. Hanne Merete Andresen, Director Pharmaceutical Affairs Norwegian Pharmacy Association - Norway
2. Andi Shirtcliffe, Clinical Chief Advisor – Pharmacy, Quality Use of Medicines, Allied Health Ministry of Health - New Zealand
3. Greg Eberhart, Registrar Alberta College of Pharmacy-Canada
4. Jorge Batista, International Affairs Lead Portuguese Pharmaceutical Society - Portugal

Meet the Champion for Change 2020!

How can stakeholders benefit the most from community pharmacy? How can pharmacy be part of a national contingency plan? What services can community pharmacy offer to help countries manage the COVID-19 crisis?
These and other questions were asked to all community pharmacists during the “Champions for Change Award 2020” survey contest, organised by FIP's Community Pharmacy Section (CPS) in collaboration with FIP's Practice Research Special Interest Group (PPR SIG) earlier this year.
After analysing the survey results, the FIP CPS Executive Committee and the FIP PPR SIG present the winner of this contest: Sarah Dineen-Griffin, PhD MPharm GradCertPharmPrac BBSci AACPA AdvPP(II) MPS, Australia.

La grippe saisonnière représente une charge de morbidité importante pour le système de santé et un risque pour plusieurs groupes de population, notamment les personnes âgées, les personnes souffrant d'affections sous-jacentes, les femmes enceintes et d'autres.
La menace d'une deuxième épidémie de COVID-19 est très réelle, et le risque que les deux virus entraînent une morbidité et une mortalité combinées ne peut être négligé.

Ce panel discutera comment plusieurs pays francophones relèvent ce défi grâce à la vaccination en pharmacie, et comment les pharmaciens peuvent contribuer à améliorer la couverture vaccinale contre la grippe et contre d’autres maladies évitables par la vaccination tout au long de la vie. Le panel discutera également du rôle du pharmacien d’officine dans la réponse aux doutes et aux mythes sur les vaccins. Il abordera également la question de la nécessaire collaboration interprofessionnelle et de sa valeur ajoutée pour les patients et pour la société, la vaccination en pharmacie représentant une extension et non un déplacement de l’accès à la vaccination.

Après ce webinaire, les participants devraient comprendre :
1. L'impact de la vaccination en pharmacie sur les taux de couverture vaccinale ;
2. Pourquoi les populations vulnérables (personnes âgées, patients chroniques et professionnels de la santé) devraient être vaccinées contre la grippe, en particulier dans le contexte de la pandémie;
3. Le rôle des pharmaciens dans l’amélioration de la couverture vaccinale tout au long de la vie contre différentes maladies;
4. Les stratégies adoptées par certains pays francophones pour augmenter la couverture vaccinale contre la grippe via les pharmacies et comment ils ont surmonté l'opposition liée aux corporations par des preuves et des approches collaboratives.

Scope: Transforming Vaccination with the FIP Development Goals: Brining practice, science and workforce together

What were the key insights and summaries from each of the events so far?

What was the one key message you gathered from that presentation, what was the main need identified from the presentation?

What is one key change you think that could be implemented to address this change?

Moderators:
Dominique Jordan, FIP President - Switzerland
Catherine Duggan, FIP CEO - the Netherlands

Panellists:
1. Ema Paulino, FIP Professional Secretary - Portugal
2. Paul Sinclair, Community Pharmacist Chair Board of Pharmaceutical Practice - Australia
3. Giovanni Pauletti, FIP Scientific Secretary - USA
4. Ross MacKinnon, Chair of FIP Board of Pharmaceutical Science, FIP - Australia
5. Ralph Altiere, Chair of FIP Education FIP - USA
6. Ian Bates, Chair of pharmacy education, UCL - UK
7. Allie Jo, Director, State Policy National Alliance of State Pharmacy Associations -
USA

Moderators:
Ralph Altiere, Dean University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, FIP Education Chair - USA

Facilitator:
Nilhan Uzman, FIP UNITWIN Programme Lead- The Netherlands

Panellists:
Catherine Duggan, FIP CEO - The Netherlands
Prosper Hiag, President African Pharmaceutical Forum - Cameroon
Mahama Duwiejua, Co- Founder, FIP-UNESCO UNITWIN Centre for Excellence in Africa - Ghana
George Ladaah Openjuru, UNESCO Chair, UNESCO - Uganda
Jennifer Nyoni, Acting Team leader Health Workforce Unit WHO Regional Office for Africa - Congo

Speakers:
Dominique Jordan, FIP President - Switzerland
Derick Munkombwe, FIP UNESCO-UNITWIN Center for Excellence in Africa Lead - Zambia
Mariam Boakye Gyasi, FIP UNESCO-UNITWIN Center for Excellence in Africa (CfEA) Lead - Ghana
Alison Williams, FIP-UNESCO UNITWIN Center for Excellence in Africa Project Coordinator - Nigeria
Aniekan Ekpenyong, Director for Africa, Global Health Focus - Nigeria
Khalid Mohammed Garba, FIP YPG Liaison Person for FIP-UNESCO UNITWIN CfEA-Nigeria
Stanley Ndigwah, FIP UNESCO-UNITWIN Center for Excellence in Africa Lead - Kenya

Presentation slides are available here.

FIP is launching a transforming vaccination globally and regionally 24 part series. In series 1, we are running 8 episodes that focus on identifying the needs for vaccine transformation across science, practice and workforce and education. In today’s event, part 6, we will be focusing on practice needs and our guest panel will discuss how the workforce and education can help transform vaccination globally and regionally discussing initial education, continuing education and the potential for progress in these areas.

Scope: Workforce & education needs: Focus on initial education

What is education currently like in your country with regards to vaccination for both initial education and continuing education?

How can this be improved?

Has education kept up with the advances in pharmacy services development?

Moderators:
Ralph Altiere, Dean University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences - USA
Ian Bates, Chair of pharmacy education UCL - UK

Panellists:

1. Lisa Nissen, Head, School of Clinical Sciences Queensland University of Technology -Australia
2. João Guedes, President, IPSF, International Pharmaceutical Students' Federation - Portugal
3. Romeo C. Ongpoy, Jr., Dean School of Pharmacy at Romeo Ongpoy - Philippines

The presentation is available here.

The presentation is available here.

Speakers:
Marianne Ivey, Professor Emerita, Pharmacy Practice and Administrative Sciences FIP - USA
Jonathan Penm, Lecturer University of Sydney - Australia

Tras la irrupción de la infección respiratoria por el nuevo coronavirus SARS-CoV-2, el desarrollo de vacunas capaces de proporcionar protección individual y poblacional frente a este virus se presenta como uno de los pilares fundamentales para controlar su expansión. Por otro lado, entre los numerosos efectos de la pandemia actual, conviene destacar los relacionados con la interrupción de los servicios básicos de salud, entre ellos, los programas de vacunación que están sufriendo importantes caídas y demoras en la mayoría de los países. En esta conferencia se abordarán las diferentes vacunas que se están en progreso para COVID-19, las tecnologías utilizadas y los adelantos en su desarrollo, así como la importancia de reestablecer y mantener los sistemas de inmunización.

Objetivos:
• Conocer las nuevas vacunas que están en desarrollado en el mundo para COVID-19.
• Describir el avance del proceso de desarrollo de las diferentes vacunas para COVID-19.
• Reconocer la importancia de la vacunación en el contexto de la pandemia.

Moderator:
Lars-Åke Söderlund, President, Community Pharmacy Section FIP President, Community Pharmacy Section
Sweden

Panellists:
1. Jelmer Faber, Community pharmacist and Co-founder of PharmaSwap.com, Royal Dutch Pharmacists’ Association - the Netherlands
2. Rikke Løvig Simonsen, Chair PharmaDanmark - Denmark
3. Frédéric Bassi, President of the Industrial Pharmacists Section French Chamber of Pharmacists - France

Moderator

• Catherine Duggan– (FIP, The Netherlands)

Speakers

• Ronald T. Piervincenzi, CEO, United States Pharmacopeia
• Ross Mckinnon – FIP Chair of Board of Pharmaceutical Sciences (College of Medicine and Public Health, Australia)
• Giovanni Pauletti – FIP Scientific Secretary (St. Louis College of Pharmacy, USA)

Moderator: Ross McKinnon (College of Medicine and Public Health, Australia)

Speakers: Colin Pouton (Monash Institute of Pharmaceutical Sciences, Australia), Nikolai Petrovsky, Founder and CEO, Vaxine (Australia)

Moderator: Ema Paulino

Panelists: Paul Sinclair, Yong Pei Chean, Faraz Ashraf, Manjiri Gharat, Indre Treciokiene, Samira Shammas

Slides

Moderators: Boone James L Winkle, Jarrod McMaugh
Panellists: Ian Bates, Lina Bader, Abeer Al-Ghananeem, Andreia Bruno-Tome, Barbel Holbein, Astrid Czock, Nadia Bukhari

Moderator: Eeva Teräsalmi

Panellists: Lucinda L. Maine, Mariet J Eksteen, Yinka Oguns

Moderator: Nai-Hwa Mei
Panellists: Anasemon Aioub, Edurne Fdez. de Gamarra Martínez

Chair: Zuzana Kusynová

Panellists: Dr Catherine Duggan, Sabiha Essack, Philip Howard, Debbie Goff, Eduardo Savio 

Moderators: Catherine Duggan, Lina Bader 

Speakers and Panelists: Roopa Dhatt, Adi Nuseirat, Carmen Peña, Claire Thompson, Nilhan Uzman, Nadia Bukhari, Vibhuti Arya, and Shane Desselle, Angie Lim Hui Li, Isaac Nii Ofoli Anang, Sherly Meilianti

Facilitators: Nilhan Uzman, Esther Anyango

Speakers: Meltem Agduk, Nadia Abdelhadi, Christina Chai, Leonora O’Brien, Vibhuti Arya Amirfar, Aya Jamal

Moderator: Rula Darwish

Speakers:Zeid Kilani, Falah Eddy, Ian Bates, Lina Bader, Dalia Bajis, Kirstie Galbraith

Panelists: Shepard Mhalaba, Asmaa Al Hagan, Desak Ernawati, Arit Udoh

Moderator: Catherine Duggan

Panellists: Ema Paulino, Ian Bates, Giovanni Pauletti

Mike Scott and Nicola Goodfellow interview

Moderator: Prof Ashok Soni

Panellists: Dr Michael Moore, Prof. Justin Ortiz

Moderator: Ema Paulino

Panellists: Bram Palache, Matthew Downham, Hanne Andresen, 

Moderator: Catherine Duggan

Panellists: Dominique Jordan, Sónia Queirós, Ann Lindstrand, Duarte Santos, Jane Barratt, Radu Costin Ganescu

Moderator: Lars-Åke Söderlund

Panellists: Glenis Kathleen Scadding, Gonçalo Sousa Pinto, Sundeep Santosh Salvi.

Speakres: Sabiha Essack and FIP Lead, Philip Howard, Catherine Duggan

The presentation is available here. Read the Covid-19 Special Collection by Pharmacy Education here. More on Pharmacy Education. 

The presentation is available here.

The presentation is available here.

OBJETIVOS
• Conocer las áreas de impacto del COVID-19 en el sistema de salud.
• Describir los efectos del COVID-19 en la salud mental de los farmacéuticos y otros trabajadores de salud.
• Desarrollar un enfoque ampliado de los resultados generados por la pandemia que sirvan para el diseño de estrategias futuras de resiliencia.

The Quantitative Sciences group is focused on quantitative data analysis to support program strategies for therapeutic projects that the foundation funds. This effort extends across all therapeutic areas in which the foundation is involved including maternal & child health, family planning, malaria, tuberculosis, neglected tropical diseases, HIV, and pandemic preparedness. He and his team are strong advocates of making research data “always FAIR and sometimes OPEN” to improve the impact data can have towards the problem it was collected to address, and beyond.

Today, Women in Global Health has more than 25,000 supporters in more than 90 countries and continues to grow. Dr. Roopa Dhatt, the Executive Director, and the global team work with a network of WGH chapters in every region to challenge power and privilege for gender equity in health by mobilizing a diverse group of emerging women health leaders, by advocating to existing global health leaders to commit to transform their own institutions, and by holding these leaders to account.  With more than chapters in all regions, Women in Global Health is changing the conversation about women’s leadership in health at global, national and local levels.

Taghreed is a professional expert in the pharmaceutical industry in the MENA region. In 2011, she founded Professional Effective Solutions, a company that offers consultation to pharmaceutical companies in formulating effective business plans; new products launch strategies to meet future market trends as well as turnaround management.

During the period from 1/2016 till 12/ 2016 she also held the position of Strategic Healthcare Advisor at the First Energy Bank in Abu Dhabi.

Taghreed had an instrumental role in the dramatic growth and success of Hikma in the MENA region. She was also an important member of the Hikma IPO team that helped take Hikma through the process of its transformation to an internationally recognized public company listed on the London Stock Exchange in Nov 2005.

Taghreed holds a BS.C degree in Pharmaceutical Sciences and two Master degrees from INSEAD Business School; “Executive MBA” in 2007 and “Consulting and Coaching for Change” in 2012.

Today, besides her consultancy services, Taghreed sits on the Board of other pharmaceutical companies in Jordan, Switzerland, Tunisia and the UAE, where she provides guidance and support.

The presentation is available here.

The presentation is available here.

Emer Cooke is currently Director, Regulation and Prequalification with the World Health Organization (WHO) in Geneva and has been with WHO since November 2016. In this role, Ms Cooke is responsible for leading WHO's global work on regulation of health technologies (medicines, vaccines, diagnostics, vector control products and devices), coordinating the regulatory teams (Prequalification, Regulatory Systems Strengthening, and Safety), and working with member states and international partners to assure the quality, safety and efficacy of appropriate health technologies. Ms. Cooke is a pharmacist with Masters degrees in Science and Business Administration from Trinity College Dublin. She has over 30 years’ experience in international regulatory affairs and spent 14 years (2002 to 2016) in management positions at the European Medicines Agency as head of Inspections and head of International affairs respectively.

The presentation is available here.

The presentation is available here.

The presentation is available here.

The presentation is available here.

The presentation is available here.

The presentation is available here.

Presentation is available here.

Presentation is available here.

Leonora is the founder & CEO of Pharmapod, a company that develops pioneering software to promote medication safety for patients worldwide. Leonora has 25 years’ experience in pharmacy practice, policy development and regulatory affairs. Past roles include working for the Pharmacy Regulator in Ireland and across 7 European countries for an international pharmacy group, implementing pan-European professional standards & anti-counterfeit programmes. She also held the position of Chief Pharmacist for the largest pharmacy chain in Ireland. This year Leonora won Business Woman of the Year in Ireland and is also a finalist in the EY Entrepreneur of the Year awards.

The presentation is available here.

•Doctor in Pharmacy, Complutense University of Madrid, Spain

•Community pharmacist

•General Secretary of Spanish Consejo General of Pharmacists (1997-2009)

•President of Spanish Consejo General of Pharmacists (2009-2015)

•Vice president of FIP (2006-2014)

•President of FIP (2014-2018)

•Grand Cross of the Civil Order of Health of Spain, 2015

•APSTJ Woman Scientist, The Academy of Pharmaceutical Scientist of Japan, 2015

•Encomienda / Medal of Pharmaceutical Merit of the Brazilian Federal Council of Pharmacists, 2010

•Academic of the Royal Academy of Pharmacy of Spain, Academic of the Ibero-American Academy of Pharmacy and Honorary Academic of the Medical-Surgical Academy of Spain

•Other recognitions and honors of Spain and other countries of the world.

The presentation is available here.

The presentation is available here.

The presentation is available here.

Andy Gray is a senior lecturer in the Division of Pharmacology, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, former vice president, bureau member, chair BPP, Hospital Pharmacy Section President, FIP; co-director of the WHO Collaborating Centre on Pharmaceutical Policy and Evidence Based Practice; Honorary Senior Scientist: Consultant Pharmacist for the Centre for the AIDS Programme of Research in South Africa; Visiting Fellow, Faculty of Pharmacy, Rhodes University, Grahamstown; Member of the World Health Organization’s Expert Panel on Drug Policies and Management; Associate Editor of the South African Pharmaceutical Journal; section editor of the Journal of Pharmaceutical Policy and Practice; and serves on the editorial board of the International Journal of Clinical Pharmacy, Health Systems and Reform, and BMC Health Services Research.

Presentation is available here.

Presentation is available here

Presentation is available here

What to do next? is a question many young, aspiring pharmaceutical scientists ask themselves as they progress in their education or early on in their careers. This webinar aims to inspire participants that are considering an academic career by showcasing two pharmaceutical researchers who have chosen an academic career. The speakers will reveal what was their motivation and how they navigated to their current position, what from their education was most valuable to their current career, and what experiences they have gained along the way.

Learning objectives:
- Participants will be able to compare an academic career in two different regions.
- Participants will learn what was required for the two speakers to reach their current role and use this to plan their own career.
- Participants will gain insights from the speakers on how to design/fulfill the key steps that make an early career researcher stand out.

Moderators:
- Sifei Han, NHMRC Early Career Fellow, Drug Delivery Disposition & Dynamics, Monash University - Australia
- Sarah Dineen-Griffin, Lecturer, Health Services Management, School of Biomedical Sciences, Charles Sturt University - Australia
- Khalid Garba Mohammed, Department of Pharmaceutics and Pharmaceutical Technology, Bayero University - Nigeria

Panellists:
- Stephanie Reuter Lange, Cancer Council Mid Career Research Fellow, University of South Australia - Australia
- Lirui Wang, Professor, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University - China

*Moderator: John Hertig

*Speakers: Mário Borges Rosa and Michael R. Cohen

On November 2016, the International Pharmaceutical Federation (FIP) brought together pharmacy leaders from across the world to set the future milestones for pharmacy education in a context of workforce development.  “There is no health without pharmacy workforce”, this slogan highlighted the importance of investing in the workforce. In addition to this, engaging youth in workforce development is unavoidable because youth are the future generation! 

FIP YPG is hosting a webinar in collaboration with the FIP Education and the International Pharmaceutical Students' Association (IPSF) on how students and young pharmacy workforce can be involved in the workforce development. If you are interested to know more about how you can engage in workforce development, this webinar is for you!

By the end of this webinar, attendees will be able to: (1) Explore current projects related to Pharmaceutical Workforce Development Goals (PWDGs); (2) Describe current project on Nanjing Assessment tools; (3) Provide examples of young student’s involvement in the Nanjing Outcomes; (4) Reflect on how pharmacy student, next generation of young pharmacists and pharmaceutical scientists can be involved.

FIP’s Hospital Pharmacy Section is organising a webinar on “Good storage and distribution practices for pharmaceutical products in hospitals”.

The correct storage and distribution and the continuous improvement of the processes involved in the supply chain from the acquisition to the administration or use of pharmaceutical products in hospitals, have a direct economic impact and improves quality assurance in patients care.

Learning objectives:

1. Understand variables that affect the stability of pharmaceutical products.

2. Understand storage and distribution processes.

3. Evaluate good storage and distribution practices that improves quality processes.

4. Highlight new technologies that benefit good practices for pharmaceutical products.

Presentation outline:

- Define variables that affect the stability of pharmaceutical products.

- Define storage and distribution processes for pharmaceutical products.

- Provide examples of good practices.

- Present new technologies that benefit good practices of storage and distribution.

Moderator: Nora Gerpe

Speakers: Martín G. Silveira and Javier Movilla

fip, webinar, hps

2016-11-03 AIM Webinar_ Leadership Development – for you and your faculty team!

2016-10-26 08.01 AcPS Webinar Leadership Development – for you and your students!

HPS - Substandard, Spurious, Falsely Labelled, Falsified, and Counterfeit (SSFFC) Medication Issues and Managem